NCT00065637View on ClinicalTrials.gov

Once Weekly Parathyroid Hormone for Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
OsteopeniaOsteoporosis
Interventions
DRUG

Teriparatide

Synthetic human parathyroid hormone

DRUG

Placebo teriparatide

Placebo injections

Trial Locations (1)

04401

St Joseph Hospital, Bangor

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of California, San Francisco

OTHER

NCT00065637 - Once Weekly Parathyroid Hormone for Osteoporosis | Biotech Hunter | Biotech Hunter